An identification of MARK inhibitors using high throughput MALDI-TOF mass spectrometry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An identification of MARK inhibitors using high throughput MALDI-TOF mass spectrometry

Published:2022-02 Issue: Volume:146 Page:112549
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Hruba Lenka,Polishchuk Pavel,Das Viswanath,Hajduch Marian,Dzubak Petr

Funder

Technologická agentura České republiky

Ministerstvo Školství, Mládeže a Tělovýchovy

Grantová Agentura České Republiky

Univerzita Palackého v Olomouci

European Regional Development Fund

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference78 articles.

1. MARK, a novel family of protein kinases that phosphorylate microtubule- associated proteins and trigger microtubule disruption;Drewes;Cell,1997

2. Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein;Timm;BMC Neurosci.,2008

3. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in alzheimer’s disease;Augustinack;Acta Neuropathol.,2002

4. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase- 3β;Reynolds;J. Neurochem.,2000

5. Non-proline-dependent protein kinases phosphorylate several sites found in tau from alzheimer disease brain;Singh;Mol. Cell. Biochem.,1996

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immediate-Early Genes as Influencers in Genetic Networks and their Role in Alzheimer’s Disease;2024-03-29

2. Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies;Medicinal Research Reviews;2024-03-26

3. Drug repurposing for Alzheimer’s disease from 2012–2022—a 10-year literature review;Frontiers in Pharmacology;2023-09-07

4. Synthesis and biological activity of bisindole derivatives as novel MARK4 inhibitors;European Journal of Medicinal Chemistry Reports;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3